Tapewire

Nasdaq · USD

RYTM

RHYTHM PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3693
SEC CIK
0001649904
Parsed reports
430

Last 12 months

Inside the activity.

0 purchase rows · 50 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202501
Jan 202600
Feb 2026023
Mar 202601
Apr 202600
May 202601
Jun 202601
Jul 202600
Aug 2026015
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 08, 2025 Filed Apr 10, 2025 21:17 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 14,060 $0.00 Strike: $6.80 $0.00
Disclosure

SEC source: 0001104659-25-033821 · tm2512047-2_4seq1.xml · derivative · entry 7

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,190

Underlying: Common Stock · 14,060 shares

Expires 2032-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
April 08, 2025 Filed Apr 10, 2025 21:17 UTC
Cramer Pamela J.Chief Human Resources Officer
SaleCommon Stock 7,030 $62.00 $435,860.00
Disclosure

SEC source: 0001104659-25-033821 · tm2512047-2_4seq1.xml · nonDerivative · entry 6

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,209

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.

Read SEC document
April 08, 2025 Filed Apr 10, 2025 21:17 UTC
Cramer Pamela J.Chief Human Resources Officer
SaleCommon Stock 6,700 $60.00 $402,000.00
Disclosure

SEC source: 0001104659-25-033821 · tm2512047-2_4seq1.xml · nonDerivative · entry 5

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,239

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.

Read SEC document
April 08, 2025 Filed Apr 10, 2025 21:17 UTC
Cramer Pamela J.Chief Human Resources Officer
SaleCommon Stock 600 $59.00 $35,400.00
Disclosure

SEC source: 0001104659-25-033821 · tm2512047-2_4seq1.xml · nonDerivative · entry 4

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,939

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.

Read SEC document
April 08, 2025 Filed Apr 10, 2025 21:17 UTC
Cramer Pamela J.Chief Human Resources Officer
SaleCommon Stock 6,430 $58.36 $375,230.37
Disclosure

SEC source: 0001104659-25-033821 · tm2512047-2_4seq1.xml · nonDerivative · entry 3

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,539

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $58.00 to $58.735 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 08, 2025 Filed Apr 10, 2025 21:17 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionCommon Stock 6,700 $27.35 $183,245.00
Disclosure

SEC source: 0001104659-25-033821 · tm2512047-2_4seq1.xml · nonDerivative · entry 2

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,969

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 08, 2025 Filed Apr 10, 2025 21:17 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionCommon Stock 14,060 $6.80 $95,608.00
Disclosure

SEC source: 0001104659-25-033821 · tm2512047-2_4seq1.xml · nonDerivative · entry 1

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,269

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 08, 2025 Filed Apr 10, 2025 21:16 UTC
Mazabraud YannEVP, Head of International
SaleCommon Stock 9,312 $61.54 $573,062.34
Disclosure

SEC source: 0001104659-25-033820 · tm2512047-1_4seq1.xml · nonDerivative · entry 2

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,620

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $61.04 to $62.00 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 08, 2025 Filed Apr 10, 2025 21:16 UTC
Mazabraud YannEVP, Head of International
SaleCommon Stock 8,438 $60.37 $509,434.97
Disclosure

SEC source: 0001104659-25-033820 · tm2512047-1_4seq1.xml · nonDerivative · entry 1

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,932

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $60.00 to $60.91 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 21, 2025 Filed Mar 24, 2025 21:47 UTC
German Christopher PaulCorporate Controller & CAO
SaleCommon Stock 344 $54.23 $18,655.12
Disclosure

SEC source: 0001104659-25-027336 · tm259548-2_4seq1.xml · nonDerivative · entry 2

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,889

F2 · kind: The sale reported in this Form 4 was effected pursuant to non-Rule 10b5-1 trading arrangement, as defined in Item 408(a) of Regulation S-K, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:47 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionRestricted Stock Units · Derivative 1,163 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-027336 · tm259548-2_4seq1.xml · derivative · entry 3

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,324

Underlying: Common Stock · 1,163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units have vested or will vest as to 25% of the total shares on each of March 20, 2024, March 20, 2025, March 20, 2026 and March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units have vested or will vest as to 25% of the total shares on each of March 20, 2024, March 20, 2025, March 20, 2026 and March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:47 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionCommon Stock 1,163 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-027336 · tm259548-2_4seq1.xml · nonDerivative · entry 1

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,233

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
March 14, 2025 Filed Mar 19, 2025 01:16 UTC
Mazabraud YannEVP, Head of International
Exercise / conversionStock Options (Right to Buy) · Derivative 75,000 $0.00 Strike: $22.28 $0.00
Disclosure

SEC source: 0001104659-25-025236 · tm259548-1_4seq1.xml · derivative · entry 4

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 75,000 shares

Expires 2030-10-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options are fully vested.

Read SEC document
March 14, 2025 Filed Mar 19, 2025 01:16 UTC
Mazabraud YannEVP, Head of International
SaleCommon Stock 55,803 $51.72 $2,886,226.03
Disclosure

SEC source: 0001104659-25-025236 · tm259548-1_4seq1.xml · nonDerivative · entry 3

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,370

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $51.31 to $52.04 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 14, 2025 Filed Mar 19, 2025 01:16 UTC
Mazabraud YannEVP, Head of International
SaleCommon Stock 19,197 $50.79 $975,046.35
Disclosure

SEC source: 0001104659-25-025236 · tm259548-1_4seq1.xml · nonDerivative · entry 2

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,173

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $50.31 to $51.26 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 14, 2025 Filed Mar 19, 2025 01:16 UTC
Mazabraud YannEVP, Head of International
Exercise / conversionCommon Stock 75,000 $22.28 $1,671,000.00
Disclosure

SEC source: 0001104659-25-025236 · tm259548-1_4seq1.xml · nonDerivative · entry 1

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,370

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 19, 2025 Filed Feb 20, 2025 02:43 UTC
Cramer Pamela J.Chief Human Resources Officer
SaleCommon Stock 982 $57.22 $56,190.04
Disclosure

SEC source: 0001104659-25-015317 · tm257103-1_4seq1.xml · nonDerivative · entry 2

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,209

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 19, 2025 Filed Feb 20, 2025 02:46 UTC
Lee Jennifer KaydenEVP, Head of North America
SaleCommon Stock 2,035 $57.22 $116,442.70
Disclosure

SEC source: 0001104659-25-015320 · tm257103-4_4seq1.xml · nonDerivative · entry 2

Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,858

F2 · kind: The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 19, 2025 Filed Feb 20, 2025 02:45 UTC
German Christopher PaulCorporate Controller & CAO
SaleCommon Stock 635 $57.22 $36,334.70
Disclosure

SEC source: 0001104659-25-015319 · tm257103-3_4seq1.xml · nonDerivative · entry 2

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,070

F3 · kind: The sale reported in this Form 4 was effected pursuant to non-Rule 10b5-1 trading arrangement, as defined in Item 408(a) of Regulation S-K, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 19, 2025 Filed Feb 20, 2025 02:48 UTC
Meeker David PDirector · President and CEO
SaleCommon Stock 9,896 $57.22 $566,249.12
Disclosure

SEC source: 0001104659-25-015322 · tm257103-6_4seq1.xml · nonDerivative · entry 2

Meeker David P · CIK 0001385155 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 201,281

F2 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 19, 2025 Filed Feb 20, 2025 02:50 UTC
Smith Hunter CChief Financial Officer
SaleCommon Stock 2,215 $57.22 $126,742.30
Disclosure

SEC source: 0001104659-25-015325 · tm257103-8_4seq1.xml · nonDerivative · entry 2

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,929

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 19, 2025 Filed Feb 20, 2025 02:49 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 1,228 $57.22 $70,266.16
Disclosure

SEC source: 0001104659-25-015324 · tm257103-7_4seq1.xml · nonDerivative · entry 2

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,509

F2 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:43 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionRestricted Stock Units · Derivative 3,300 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015317 · tm257103-1_4seq1.xml · derivative · entry 5

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,900

Underlying: Common Stock · 3,300 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F5 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

F5 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:43 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionCommon Stock 3,300 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-015317 · tm257103-1_4seq1.xml · nonDerivative · entry 1

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,191

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:46 UTC
Lee Jennifer KaydenEVP, Head of North America
Exercise / conversionRestricted Stock Units · Derivative 5,500 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015320 · tm257103-4_4seq1.xml · derivative · entry 5

Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 5,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F5 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

F5 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:46 UTC
Lee Jennifer KaydenEVP, Head of North America
Exercise / conversionCommon Stock 5,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-015320 · tm257103-4_4seq1.xml · nonDerivative · entry 1

Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,893

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:45 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionRestricted Stock Units · Derivative 1,807 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015319 · tm257103-3_4seq1.xml · derivative · entry 5

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,418

Underlying: Common Stock · 1,807 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F6 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

F6 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:45 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionCommon Stock 1,807 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-015319 · tm257103-3_4seq1.xml · nonDerivative · entry 1

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,705

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F2 · balance_after: Includes 103 additional shares acquired under the Issuer's Employee Stock Purchase Plan.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:48 UTC
Meeker David PDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 21,250 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015322 · tm257103-6_4seq1.xml · derivative · entry 5

Meeker David P · CIK 0001385155 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,750

Underlying: Common Stock · 21,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F5 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

F5 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:48 UTC
Meeker David PDirector · President and CEO
Exercise / conversionCommon Stock 21,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-015322 · tm257103-6_4seq1.xml · nonDerivative · entry 1

Meeker David P · CIK 0001385155 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,177

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:50 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 6,600 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015325 · tm257103-8_4seq1.xml · derivative · entry 5

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,800

Underlying: Common Stock · 6,600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F5 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

F5 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:50 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionCommon Stock 6,600 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-015325 · tm257103-8_4seq1.xml · nonDerivative · entry 1

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,144

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:49 UTC
Shulman JosephChief Technical Officer
Exercise / conversionRestricted Stock Units · Derivative 4,125 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015324 · tm257103-7_4seq1.xml · derivative · entry 5

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,375

Underlying: Common Stock · 4,125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F5 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

F5 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:49 UTC
Shulman JosephChief Technical Officer
Exercise / conversionCommon Stock 4,125 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-015324 · tm257103-7_4seq1.xml · nonDerivative · entry 1

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,737

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:47 UTC
Mazabraud YannEVP, Head of International
Exercise / conversionRestricted Stock Units · Derivative 5,500 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015321 · tm257103-5_4seq1.xml · derivative · entry 4

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 5,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

F4 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Read SEC document
February 16, 2025 Filed Feb 20, 2025 02:47 UTC
Mazabraud YannEVP, Head of International
Exercise / conversionCommon Stock 5,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-015321 · tm257103-5_4seq1.xml · nonDerivative · entry 1

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,370

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:44 UTC
Garfield AlastairChief Scientific Officer
GrantStock Options (Right to Buy) · Derivative 40,000 $0.00 Strike: $56.69 $0.00
Disclosure

SEC source: 0001104659-25-015318 · tm257103-2_4seq1.xml · derivative · entry 2

Garfield Alastair · CIK 0002027261 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2035-02-13

F3 · derivative.exercise_date: The options vest and become exercisable, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date, as to 6.25% of the total number of shares of common stock subject to the options upon the Reporting Person's completion of each successive three months of service to the Issuer after February 14, 2025, such that the option shall be fully vested and exercisable on February 14, 2029.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:44 UTC
Garfield AlastairChief Scientific Officer
GrantRestricted Stock Units · Derivative 26,650 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015318 · tm257103-2_4seq1.xml · derivative · entry 1

Garfield Alastair · CIK 0002027261 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,650

Underlying: Common Stock · 26,650 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:43 UTC
Cramer Pamela J.Chief Human Resources Officer
GrantStock Options (Right to Buy) · Derivative 30,000 $0.00 Strike: $56.69 $0.00
Disclosure

SEC source: 0001104659-25-015317 · tm257103-1_4seq1.xml · derivative · entry 4

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-02-13

F4 · derivative.exercise_date: The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:43 UTC
Cramer Pamela J.Chief Human Resources Officer
GrantRestricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015317 · tm257103-1_4seq1.xml · derivative · entry 3

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:46 UTC
Lee Jennifer KaydenEVP, Head of North America
GrantStock Options (Right to Buy) · Derivative 55,000 $0.00 Strike: $56.69 $0.00
Disclosure

SEC source: 0001104659-25-015320 · tm257103-4_4seq1.xml · derivative · entry 4

Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2035-02-13

F4 · derivative.exercise_date: The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:46 UTC
Lee Jennifer KaydenEVP, Head of North America
GrantRestricted Stock Units · Derivative 36,650 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015320 · tm257103-4_4seq1.xml · derivative · entry 3

Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,650

Underlying: Common Stock · 36,650 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:45 UTC
German Christopher PaulCorporate Controller & CAO
GrantStock Options (Right to Buy) · Derivative 5,400 $0.00 Strike: $56.69 $0.00
Disclosure

SEC source: 0001104659-25-015319 · tm257103-3_4seq1.xml · derivative · entry 4

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,400

Underlying: Common Stock · 5,400 shares

Expires 2035-02-13

F5 · derivative.exercise_date: The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:45 UTC
German Christopher PaulCorporate Controller & CAO
GrantRestricted Stock Units · Derivative 7,225 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015319 · tm257103-3_4seq1.xml · derivative · entry 3

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,225

Underlying: Common Stock · 7,225 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

F4 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:48 UTC
Meeker David PDirector · President and CEO
GrantStock Options (Right to Buy) · Derivative 200,000 $0.00 Strike: $56.69 $0.00
Disclosure

SEC source: 0001104659-25-015322 · tm257103-6_4seq1.xml · derivative · entry 4

Meeker David P · CIK 0001385155 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2035-02-13

F4 · derivative.exercise_date: The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:48 UTC
Meeker David PDirector · President and CEO
GrantRestricted Stock Units · Derivative 133,350 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015322 · tm257103-6_4seq1.xml · derivative · entry 3

Meeker David P · CIK 0001385155 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,350

Underlying: Common Stock · 133,350 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:50 UTC
Smith Hunter CChief Financial Officer
GrantStock Options (Right to Buy) · Derivative 62,500 $0.00 Strike: $56.69 $0.00
Disclosure

SEC source: 0001104659-25-015325 · tm257103-8_4seq1.xml · derivative · entry 4

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2035-02-13

F4 · derivative.exercise_date: The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:50 UTC
Smith Hunter CChief Financial Officer
GrantRestricted Stock Units · Derivative 41,650 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015325 · tm257103-8_4seq1.xml · derivative · entry 3

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,650

Underlying: Common Stock · 41,650 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:49 UTC
Shulman JosephChief Technical Officer
GrantStock Options (Right to Buy) · Derivative 37,500 $0.00 Strike: $56.69 $0.00
Disclosure

SEC source: 0001104659-25-015324 · tm257103-7_4seq1.xml · derivative · entry 4

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-02-13

F4 · derivative.exercise_date: The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 02:49 UTC
Shulman JosephChief Technical Officer
GrantRestricted Stock Units · Derivative 25,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-015324 · tm257103-7_4seq1.xml · derivative · entry 3

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.